GAIN-OF-FUNCTION BCL-2 INHIBITORS

摘要

Compounds are described that are useful for treating an apoptosis-associated disease, which are specifically cytotoxic to tumor cells that are overexpressing BcI-XL, and are much less cytotoxic in isogenic cells that are not overexpressing BcI-XL. Methods of using such compounds to treat apoptosis-associated disease is also described.